For example, the aberrant level of IGF2BP3 is detected in the majority of invasive triple-negative breast carcinomas [45, 46], while the expression of IGF2BP3 is only elevated in adenoid cystic carcinomas in basal-like BC [47, 48]. The gene discussed is IGF2BP3; the disease is triple-negative breast carcinoma.